 previous article in this issue | next article in this issue  |
|
Document Details : Title: Metabolic (glycaemic, lipidic) and blood pressure control in 101 type 2 diabetic patients on first admission to diabetes centre Author(s): LIENART D, PREUMONT V, ALEXOPOULOU O, DONCKIER J, COLSON A, HERMANS MP, BUYSSCHAERT M Journal: Acta Clinica Belgica Volume: 61 Issue: 3 Date: 2006 Pages: 127-133 DOI: 10.2143/ACB.61.3.1002681 Abstract : The aim of our study was to analyse the quality of metabolic and blood pressure control in a cohort of 101 patients with type 2 diabetes (54 males; 47 females), previously followed in primary care settings and admitted for the first time to the diabetes centres of Saint-Luc (n=66) or Mont-Godinne (n=35) University Hospitals. Age and (known) duration of diabetes were 64±12 and 6±7 years (mean±SD), respectively. Body mass index was 31±7 kg/m2. Systolic and diastolic blood pressures were 140±12 and 81±11 mmHg. Homeostasis model assessment (HOMA) showed insulin sensitivity at 63±32% and β-cell function at 49±44% (n=34). Forty-seven percent of patients received either diet alone or combined with an oral antidiabetic monotherapy. Seven-teen percent of all patients were on insulin monotherapy or associated with oral drugs. HbA1c was 9.0 ± 2.3%, with 22% of patients within HbA1c targets of ≤ 7%. Only a subset of patients reached international targets of care in terms of blood pressure and lipidic profile, despite antihypertensive and lipid-lowering agents in 62% and 36% of patients, respectively. Forty-five percent of individuals had at least one diabetesrelated long-term complication. In view of this unsatisfactory control, our results suggest that “anti-diabetic” treatment should be intensified earlier in primary care settings. |
